From: Vancomycin dosing design method considering risk factors for nephrotoxicity
AUCss (mg·h/mL) | Low Risk groups (n = 108) | High Risk groups (n = 104) | All cases (n = 212) |
---|---|---|---|
400 | 2.1% | 16.8% | 8.2% |
500 | 4.7% | 23.3% | 13.4% |
575 | 8.4% | 29.3% | 18.9% |
600 | 10.2% | 31.4% | 21.1% |
650 | 14.6% | 36.0% | 26.0% |